-
1
-
-
0036499029
-
INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy
-
Minsky BD, Pajak TF, Ginsberg RJ et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J. Clin. Oncol. 2002; 20: 1167-74.
-
(2002)
J. Clin. Oncol
, vol.20
, pp. 1167-1174
-
-
Minsky, B.D.1
Pajak, T.F.2
Ginsberg, R.J.3
-
2
-
-
0842286828
-
Definitive chemoradiation in patients with inoperable oesophageal carcinoma
-
Crosby TD, Brewster AE, Borley A et al. Definitive chemoradiation in patients with inoperable oesophageal carcinoma. Br. J. Cancer 2004; 90: 70-5.
-
(2004)
Br. J. Cancer
, vol.90
, pp. 70-75
-
-
Crosby, T.D.1
Brewster, A.E.2
Borley, A.3
-
3
-
-
0037443481
-
Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus: A practice guideline
-
Wong RK, Malthaner RA, Zuraw L et al. Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus: a practice guideline. Int. J. Radiat. Oncol. Biol. Phys. 2003; 55: 930-42.
-
(2003)
Int. J. Radiat. Oncol. Biol. Phys
, vol.55
, pp. 930-942
-
-
Wong, R.K.1
Malthaner, R.A.2
Zuraw, L.3
-
4
-
-
0035863382
-
Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma
-
Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J. Clin. Oncol. 2001; 19: 305-13.
-
(2001)
J. Clin. Oncol
, vol.19
, pp. 305-313
-
-
Urba, S.G.1
Orringer, M.B.2
Turrisi, A.3
Iannettoni, M.4
Forastiere, A.5
Strawderman, M.6
-
5
-
-
10044285985
-
Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients
-
Liao Z, Zhang Z, Jin J et al. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 2004; 60: 1484-93.
-
(2004)
Int. J. Radiat. Oncol. Biol. Phys
, vol.60
, pp. 1484-1493
-
-
Liao, Z.1
Zhang, Z.2
Jin, J.3
-
6
-
-
0037434412
-
Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus
-
Kaneko K, Ito H, Konishi K et al. Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus. Br. J. Cancer 2003; 88: 18-24.
-
(2003)
Br. J. Cancer
, vol.88
, pp. 18-24
-
-
Kaneko, K.1
Ito, H.2
Konishi, K.3
-
7
-
-
0030910460
-
CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma
-
Yamamoto K, Oka M, Hayashi H, Tangoku A, Gondo T, Suzuki T. CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma. Cancer 1997; 79: 1647-55.
-
(1997)
Cancer
, vol.79
, pp. 1647-1655
-
-
Yamamoto, K.1
Oka, M.2
Hayashi, H.3
Tangoku, A.4
Gondo, T.5
Suzuki, T.6
-
8
-
-
0034306852
-
CYFRA 21-1 determination in patients with esophageal squamous cell carcinoma: Clinical utility for detection of recurrences
-
Kawaguchi H, Ohno S, Miyazaki M et al. CYFRA 21-1 determination in patients with esophageal squamous cell carcinoma: clinical utility for detection of recurrences. Cancer 2000; 89: 1413-17.
-
(2000)
Cancer
, vol.89
, pp. 1413-1417
-
-
Kawaguchi, H.1
Ohno, S.2
Miyazaki, M.3
-
9
-
-
0037388473
-
Prognostic significance of CYFRA 21-1 in patients with esophageal squamous cell carcinoma
-
Shimada H, Nabeya Y, Okazumi S et al. Prognostic significance of CYFRA 21-1 in patients with esophageal squamous cell carcinoma. J. Am. Coll. Surg. 2003; 196: 573-8.
-
(2003)
J. Am. Coll. Surg
, vol.196
, pp. 573-578
-
-
Shimada, H.1
Nabeya, Y.2
Okazumi, S.3
-
10
-
-
0033739632
-
CYFRA 21-1 serum analysis in patients with esophageal cancer
-
Brockmann JG, St Nottberg H, Glodny B, Sprakel B, Senninger N. CYFRA 21-1 serum analysis in patients with esophageal cancer. Clin. Cancer Res. 2000; 6: 4249-52.
-
(2000)
Clin. Cancer Res
, vol.6
, pp. 4249-4252
-
-
Brockmann, J.G.1
St Nottberg, H.2
Glodny, B.3
Sprakel, B.4
Senninger, N.5
-
11
-
-
16544372409
-
Detection of bone marrow micrometastasis in esophageal cancer patients by immunomagnetic separation
-
Nakamura T, Matsunami K, Hayashi K, Ota M, Ide H, Takasaki K. Detection of bone marrow micrometastasis in esophageal cancer patients by immunomagnetic separation. Oncol. Rep. 2004; 11: 999-1003.
-
(2004)
Oncol. Rep
, vol.11
, pp. 999-1003
-
-
Nakamura, T.1
Matsunami, K.2
Hayashi, K.3
Ota, M.4
Ide, H.5
Takasaki, K.6
-
12
-
-
3242725210
-
CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients
-
Muley T, Dienemann H, Ebert W. CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients. Anticancer Res. 2004; 24: 1953-6.
-
(2004)
Anticancer Res
, vol.24
, pp. 1953-1956
-
-
Muley, T.1
Dienemann, H.2
Ebert, W.3
-
13
-
-
3042683689
-
Circulating nucleosomes predict the response to chemotherapy in patients with advanced non-small cell lung cancer
-
Holdenrieder S, Stieber P, von Pawel J et al. Circulating nucleosomes predict the response to chemotherapy in patients with advanced non-small cell lung cancer. Clin. Cancer Res. 2004; 10: 5981-7.
-
(2004)
Clin. Cancer Res
, vol.10
, pp. 5981-5987
-
-
Holdenrieder, S.1
Stieber, P.2
von Pawel, J.3
-
14
-
-
0027279541
-
CYFRA 21-1. A new marker in lung cancer
-
Stieber P, Hasholzner U, Bodenmuller H et al. CYFRA 21-1. A new marker in lung cancer. Cancer 1993; 72: 707-13.
-
(1993)
Cancer
, vol.72
, pp. 707-713
-
-
Stieber, P.1
Hasholzner, U.2
Bodenmuller, H.3
-
15
-
-
0034036462
-
Serum CYFRA 21-1 in cervical cancer patients treated with radiation therapy
-
Suzuki Y, Nakano T, Ohno T, Abe A, Morita S, Tsujii H. Serum CYFRA 21-1 in cervical cancer patients treated with radiation therapy. J. Cancer Res. Clin. Oncol. 2000; 126: 332-6.
-
(2000)
J. Cancer Res. Clin. Oncol
, vol.126
, pp. 332-336
-
-
Suzuki, Y.1
Nakano, T.2
Ohno, T.3
Abe, A.4
Morita, S.5
Tsujii, H.6
-
16
-
-
3543147149
-
Prospective validation of serum CYFRA 21-1, beta-2-microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapy
-
Ma BB, Leungm SF, Hui EP et al. Prospective validation of serum CYFRA 21-1, beta-2-microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapy. Cancer 2004; 101: 776-81.
-
(2004)
Cancer
, vol.101
, pp. 776-781
-
-
Ma, B.B.1
Leungm, S.F.2
Hui, E.P.3
-
17
-
-
4644325834
-
Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer
-
Nakata B, Takashima T, Ogawa Y, Ishikawa T, Hirakawa K. Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer. Br. J. Cancer 2004; 91: 873-8.
-
(2004)
Br. J. Cancer
, vol.91
, pp. 873-878
-
-
Nakata, B.1
Takashima, T.2
Ogawa, Y.3
Ishikawa, T.4
Hirakawa, K.5
-
18
-
-
0037714432
-
Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervix
-
Ohno T, Nakayama Y, Nakamoto S et al. Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervix. Cancer 2003; 97: 3114-20.
-
(2003)
Cancer
, vol.97
, pp. 3114-3120
-
-
Ohno, T.1
Nakayama, Y.2
Nakamoto, S.3
|